Medicare Enrolled

Dr. Edward Dabrowski, M.D.

Physical Medicine & Rehabilitation · Roseville, MI
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
25100 KELLY RD, Roseville, MI 48066
2485530010
In practice since 2006 (20 years)
NPI: 1548230253 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Dabrowski from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dabrowski? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Dabrowski

Dr. Edward Dabrowski is a physical medicine & rehabilitation specialist in Roseville, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Dabrowski performed 43,405 Medicare services across 274 unique beneficiaries.

Between the years covered by Open Payments, Dr. Dabrowski received a total of $172,674 from 68 pharmaceutical and/or device companies across 791 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in physical medicine & rehabilitation. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Dabrowski is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 0% volume in MI $172,674 industry payments

Medicare Practice Summary

Medicare Utilization ↗
43,405
Medicare services
Top 0% in MI for physical medicine & rehabilitation
274
Unique beneficiaries
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,170 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Botox injection, per unit
An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered.
29,600 $5 $17
AbobotulinumtoxinA injection, 5 units
An injection of abobotulinumtoxinA administered in a quantity of 5 units.
13,320 $6 $19
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
206 $61 $171
Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity 124 $69 $291
Chemical nerve block injection, 1-4 muscles
An injection of a chemical agent to paralyze specific muscles in an arm or leg. This procedure targets one to four muscles in the first extremity treated.
119 $110 $424
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
36 $93 $230
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$172,674
Total received (2018-2024)
Avg $24,668/year across 7 years
Top 0% in MI for physical medicine & rehabilitation
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
68
Companies
791
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$121,206 (70.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$40,931 (23.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,538 (6.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$18,619
2023
$26,043
2022
$36,163
2021
$10,041
2020
$6,710
2019
$48,300
2018
$26,798

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ACADIA Pharmaceuticals Inc
$9,211
Ipsen Biopharmaceuticals, Inc
$7,493
ABBVIE INC.
$498
Biogen, Inc.
$285
Neurelis, Inc.
$220
Merz Pharmaceuticals, LLC
$202
Novartis Pharmaceuticals Corporation
$159
IRONSHORE PHARMACEUTICALS INC.
$90
Neurocrine Biosciences, Inc.
$90
Lilly USA, LLC
$64
Corium, LLC
$46
Philips North America LLC
$46
Electromed, Inc.
$40
REVANCE THERAPEUTICS, INC.
$35
PFIZER INC.
$31
Teva Pharmaceuticals USA, Inc.
$29
Alexion Pharmaceuticals, Inc.
$26
Otsuka Pharmaceutical Development & Commercialization, Inc.
$21
Supernus Pharmaceuticals, Inc.
$16
JAZZ PHARMACEUTICALS INC.
$15
Top 3 companies account for 92.4% of 2024 payments
All-time payments by company (2018-2024) ›
Ipsen Biopharmaceuticals, Inc
$94,792
ABBVIE INC.
$17,019
US WorldMeds, LLC
$10,738
Allergan Inc.
$10,631
ACADIA Pharmaceuticals Inc
$9,381
AbbVie Inc.
$7,025
Ipsen Innovation
$5,311
Allergan, Inc.
$4,180
PTC Therapeutics, Inc.
$3,238
Ipsen Pharma SAS
$1,460
Merz Pharmaceuticals, LLC
$1,390
MDD US Operations, LLC
$1,234
Merz North America, Inc.
$825
Biogen, Inc.
$579
Neurelis, Inc.
$421
Novartis Pharmaceuticals Corporation
$398
Electromed, Inc.
$392
Alexion Pharmaceuticals, Inc.
$344
AveXis
$316
Supernus Pharmaceuticals, Inc.
$203
Neurocrine Biosciences, Inc.
$165
GENZYME CORPORATION
$150
Amgen Inc.
$147
Saol Therapeutics Inc.
$144
BOSTON SCIENTIFIC CORPORATION
$121
Takeda Pharmaceuticals U.S.A., Inc.
$113
CSL Behring
$111
JAZZ PHARMACEUTICALS INC.
$110
UCB, Inc.
$108
Lilly USA, LLC
$105
Alnylam Pharmaceuticals Inc.
$103
Teva Pharmaceuticals USA, Inc.
$101
IRONSHORE PHARMACEUTICALS INC.
$90
Piramal Critical Care
$81
Biohaven Pharmaceutical Holding Company Ltd.
$78
Sunovion Pharmaceuticals Inc.
$72
Aprecia Pharmaceuticals, LLC
$68
SK Life Science, Inc.
$65
Ironshore Pharmaceuticals Inc.
$62
Philips Electronics North America Corporation
$60
EISAI INC.
$60
Corium, LLC
$57
TG THERAPEUTICS, INC.
$49
Philips North America LLC
$46
Genentech USA, Inc.
$46
Grifols USA, LLC
$42
Zyla Life Sciences
$39
REVANCE THERAPEUTICS, INC.
$35
PFIZER INC.
$31
Acorda Therapeutics, Inc
$25
Zyla Life Sciences, Inc.
$25
Amneal Pharmaceuticals LLC
$23
Medtronic, Inc.
$22
Adamas Pharmaceuticals, Inc.
$22
Otsuka America Pharmaceutical, Inc.
$21
Otsuka Pharmaceutical Development & Commercialization, Inc.
$21
Akcea Therapeutics, Inc.
$20
Azurity Pharmaceuticals, Inc.
$18
Boston Scientific Corporation
$18
Greenwich Biosciences, Inc.
$17
ARBOR PHARMACEUTICALS, INC.
$17
Shire North American Group Inc
$14
Eisai Inc.
$13
Medtronic USA, Inc.
$12
Avanir Pharmaceuticals, Inc.
$12
Biohaven Pharmaceuticals, Inc.
$12
Promius Pharma LLC
$12
Strongbridge US INC.
$11
Top 3 companies account for 71.0% of all-time payments
Associated products mentioned in payments ›
(7999) SRC Und · (8874) inCourage · (AK6) Vest Therapy · ACTIVA · ACTIVA PC · AFINITOR · AJOVY · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Aimovig · Austedo XR · Azstarys · BOTOX · BOTOX - NEUROLOGY · BOTOX THERAPEUTIC · BRIUMVI · Briviact · Cimzia · DAXXIFY · DAYBUE · DYSPORT · Dysport · EMFLAZA · EMGALITY · EPIDIOLEX · Epidiolex · Fycompa · GABLOFEN · GAMMAGARD · GENERAL DBS · GOCOVRI · Gamunex-C · General - Pain Management · Hizentra · INBRIJA · INGREZZA · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · KESIMPTA · KEVEYIS · LUMIZYME · Lioresal (baclofen) · Lioresal Intrathecal (baclofen injection) · MAYZENT · MYOBLOC · NUEDEXTA · NUPLAZID · NURTEC ODT · OCREVUS · ONPATTRO · OXTELLAR XR · Ongentys · Onivyde · POMPE - DISEASE · Privigen · QELBREE · QULIPTA · Qelbree · REXULTI · RYTARY · SMARTVEST · SOLIRIS · SPINRAZA · SPRIX · Skyclarys · Soliris · Spritam · TEGSEDI · TYSABRI · Triptodur · UBRELVY · ULTOMIRIS · VALTOCO · VUMERITY · VYVANSE · XADAGO · XEOMIN · XYWAV · Xadago · Xeomin · ZOLGENSMA · Zembrace
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (70%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in physical medicine & rehabilitation and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for physical medicine & rehabilitation in MI.

Looking for a physical medicine & rehabilitation specialist in Roseville?
Compare physical medicine & rehabilitations in the Roseville area by procedure volume, costs, and industry payment transparency.
Browse physical medicine & rehabilitations nearby

Geographic Context

Physical medicine & rehabilitations within 10 mi
219
Per 100K population
25.0
County median income
$76,399
Nearest hospital
Henry Ford Health Warren Hospital
4.1 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Dabrowski is a mixed practice specialist, with above-average Medicare volume (top 0% in MI), with speaking/promotional industry engagement in the top 0% of MI peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Dabrowski experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Dabrowski performed 29,600 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dabrowski receive payments from pharmaceutical companies?
Yes. Dr. Dabrowski received a total of $172,674 from 68 companies across 791 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dabrowski's costs compare to other physical medicine & rehabilitations in Roseville?
Dr. Dabrowski's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dabrowski) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →